Lower levels of eicosapentaenoic acid and the ratio of docosahexaenoic acid to arachidonic acid in sera of patients with multi-infarct dementia

Journal of Clinical Biochemistry and Nutrition

Volumn 36, Issue 3, 2005, Pages 83-89

  Hirai, Kazuko ^a   Kozuki, Mikiko ^a   Miyanaga, Kazuo ^b   Miyagawa, Fumio ^c   Takezoe, Reiko ^d   Hasegawa, Megumi ^e   Mori, Masahiro ^a  

^a SENRI KINRAN UNIVERSITY   (Japan)

^b Gunma Pref Mental Health Center   (Japan)

^c Chigasaki Laboratory   (Japan)

^d Osaka Prefecture University   (Japan)

^e TENSHI COLLEGE   (Japan)

Author keywords

Dementia; DHA AA ratio; EPA; EPA AA ratio; n 3PUFA; Serum

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

AGED; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; MULTIINFARCT DEMENTIA; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 27244453433     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.36.83     Document Type: Review

References (25)

1. Chapman, D.: Biomembrane fluidity: the concept and its development in membrane fluidity, in Biology, Vol. 2, General Principles, ed. by Aaloia, R. C., Academic Press, New York, pp. 5-42, 1993.
2. Martinez, M. and Mougan, I.: Fatty acid composition of human brain phospholipids during normal development. J. Neurochem., 71, 2528-2533, 1998.
3. Soderberg, M., Edlund, C., Kristensson, K., and Dallner, G.: Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids, 26, 421-428, 1991.
4. Horrobin, D.F., Manku, M.S., Hillman, H., Iain, A., and Glen, M.: Fatty acid levels in the brains of schizophrenics and normal controls. Biol. Psychiatry, 30, 795-805, 1991.
5. Conquer, J.A., Tierney, M.C., Zecevic, J., Bettger, W.J., and Fisher, R.H.: Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids, 35, 1305-1312, 2000.
6. Kyle, D.J., Schaefer, E., Patton, G., and Beiser, A.: Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia. Lipids, 34, Suppl., S245, 1999.
7. Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., and Hirayama, T.: Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids, 34, Suppl., S345-S346, 1999.
8. Bang, H.O., Dyerberg, J., and Hjome, N.: The composition of food consumed by Greenland Eskimos. Acta Med. Scand., 200, 69-73, 1976.
9. Kromhout, D.: n-3 Fatty acids and coronary heart disease: epidemiology from Eskimos to Western populations. J. Int. Med., 225, Suppl. 1, 47-51, 1989.
10. Park, Y. and Harris, W.: EPA, but not DHA, decreases mean platelet volume in normal subjects. Lipids, 37, 941-946, 2002.
11. Harris, W.S.: Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J. Lipid Res., 30, 785-807, 1989.
12. Von Schacky, C.V. and Weber, P.C.: Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J. Clin. Invest., 76, 2446-2450, 1985.
13. Weber, P.C. and Leaf, A.: Cardiovascular effects of n-3 fatty acids. World Rev. Nutr. Diet Basel Karger, 66, 218-232, 1991.
14. Nair, S.S.D., Leitch, J.W., Falconer, J., and Garg, M.L.: Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J. Nutr., 127, 383-393, 1997.
15. Hirai, K., Asano, Y., Kakesu, M., Higuchi, H., Nakanishi, M., Maeda, M., and Sonoda, M.: Reduction in n-3 PUFA levels and EPA/AA ratio in serum after desert travels in China. Jpn. J. Hyg., 58, 275-280, 2003 (in Japanese).
16. Dyerberg, J., Bang, H.O., Stoffersen, E., Moncada, S., and Vane, J. R.: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet, ii, 117-119, 1978.
17. Hirai, K., Horiuchi, R., Ohono, Y., Higuchi, H., and Asano, Y.: Lower eicosapentaenoic acid and higher arachidonic acid levels in sera of young adults in the Netherlands than in Japan. Environ. Health Prev. Med., 5, 60-65, 2000.
18. Horrocks, L.A. and Yeo, Y.K.: Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res., 40, 211-225, 1999.
19. Hamazaki, T., Sawazaki, S., Itomura, M., Asaoka, E., Nagao, Y., Nishikmura, N., Yazawa, K., Kuwamori, T., and Kobayashi, M.: The effect of docosahexaenoic acid on aggression in young adults. J. Clin. Invest., 97, 1129-1133, 1996.
20. Hodgson, J.M., Wahlqvist, M.L., Boxall, J.A., and Balazs, N.D.: Can linoleic acid contribute to coronary artery disease? Am. J. Clin. Nutr., 58, 228-234, 1993.
21. Leaf, A. and Weber, P.C.: Cardiovascular effects of n-3 fatty acids. N. Engl. J. Med., 318, 549-557, 1988.
22. Meydani, M.: Nutrition interventions in aging and age-associated disease. Ann. N. Y. Acad. Sci., 928, 226-235, 2001.
23. Sibai, A.M., Zard, C., Adra, N., Baydoun, M., and Hwalla, N.: Variations in nutritional status of elderly men and women according to place of residence. Gerontology, 49, 215-224, 2003.
24. Harman, D.: Aging: a theory based on free radical and radiation chemistry. J. Gerontol., 11, 298-300, 1956.
25. Kaneko, T.: Aging and the accumulation of oxidative damage to DNA. J. Clin. Biochem. Nutr., 34, 51-60, 2003.